peripheral arterial disease 13 and mortality in patients with cancer. 14 African Americans (AAs) have higher mean levels of D-dimer than Europeans, independent of other CVD risk factors. [15] [16] [17] However, the relationship of D-dimer to CVD events specifically in AAs has only been addressed in one recent study. 7 D-dimer levels are also higher in women than in men, for unknown reasons. 6, 8, 9 Family-based heritability studies and genome-wide association studies, including mainly individuals of European descent, have shown significant heritability for D-dimer, and variants in 3 coagulation factor-related loci (F3 [coagulation factor III], F5 [coagulation factor V], and FGA [fibrinogen alpha]/FGG [fibrinogen gamma]) have been associated with D-dimer. 18 Despite their higher D-dimer levels, little is known about the genetic architecture or environmental correlates of D-dimer in AAs or factors that account for higher D-dimer in women compared with men.
We measured baseline D-dimer in 4163 AAs from the JHS (Jackson Heart Study), of whom 2980 had available whole genome sequencing data through the National Heart, Lung, and Blood Institute TOPMed (Trans-Omics for Precision Medicine) project. We assessed the environmental and genetic correlates of D-dimer, as well as the association of baseline D-dimer with incident CVD events and all-cause mortality in JHS. We then performed whole genome sequencing association analysis, including coding and noncoding genetic variants, which encompass African population-specific variants that may not be captured by conventional genome-wide association study genotyping platforms. For any genome-wide significant loci, we tested for sex by genotype interaction. Finally, we sought replication and follow-up of sex-or ancestry-specific genetic association findings using independent samples from the MESA (Multi-Ethnic Study of Atherosclerosis), CHS (Cardiovascular Health Study), FHS (Framingham Heart Study), and REGARDS (Reasons for Geographic and Racial Differences in Stroke) studies.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Genetic and Environmental Correlates of D-Dimer Levels in JHS AAs
Older age, female sex, and higher body mass index were each strongly and independently associated with higher D-dimer, using a Bonferroni correction for multiple comparisons (P<0.004; Table 1 ; Figure I in the online-only Data Supplement). Adjusting for age and sex, heritability (h 2 ) of D-dimer was estimated as 0.284 (SE=0.057, P=3.75×10 -9 ). In age-and sex-adjusted models or multivariate adjusted models (Table 1 ; Figure I in the online-only Data Supplement), higher C-reactive protein and higher fibrinogen were each associated with higher D-dimer. Greater estimated African ancestry percentage was nominally associated with higher D-dimer levels in a model adjusted for CVD risk factors.
Association of D-Dimer Levels With Incident CVD Events and Mortality in JHS
In minimally and fully adjusted models, higher D-dimer was nominally associated with increased hazard for CHD, stroke, and all-cause mortality (all P≤0.039; 
Whole Genome Sequence Association Analysis of D-Dimer in JHS AAs
We performed both (1) single-variant association tests and (2) gene-based association tests of aggregated variants with a minor allele frequency <5%. Manhattan plots of the single-variant whole genome association results and gene-based rare variant results are displayed in Figure II in the online-only Data Supplement. No significant systematic inflation was observed on QQ plots ( Figure  III in the online-only Data Supplement); the calculated genomic inflation factor (λ) was 1.006 for single-variant analysis and 1.06 for gene-based analysis. Two loci, on chromosomes 1 (near F3) and 11 (HBB), reached significance in single variant testing ( Figure IIA in the online-only Data Supplement). HBB also was significantly associated with D-dimer levels in gene-based testing (P=2.35×10 -10 ; Figure IIB in the online-only Data Supplement). These are described further in detail below.
Of other single variants previously associated with D-dimer, we observed significance and the same direction of association (β=0.112, P=0.01, effect allele frequency [EAF] 10.1%) for the F5 locus variant (rs6687813) associated with D-dimer in Europeans. 18 We also observed a concordant direction of association for rs6025 (FV Leiden; β=0.277, P=0.093, EAF 0.6%), 16 a well-studied variant at this locus associated with venous thromboembolism (VTE) risk. 19 The 
Chromosome 1 Locus Near F3
The chromosome 1 signal was an intergenic locus near tissue factor (TF; F3, top variant rs2022030, β=0.284, SE=0.043, P=3.24×10 -11 , EAF 10.3%, explained 1.47% of the phenotypic variance). A LocusZoom plot 21 is displayed in Figure IV in the online-only Data Supplement. A total of 9 variants at the chr 1 locus were significant at the 1×10 -9 level, including 2 index SNPs (single nucleotide polymorphisms) previously associated with D-dimer in European genome-wide association studies (rs12029080 18 and rs2022309 22 ). However, none of these variants remained significant after conditioning on the lead variant rs2022030 ( Figure VA in the online-only Data Supplement). Similarly, adjustment for lead European metaanalysis variant rs12029080 greatly attenuated the association Model 1 is unadjusted. Model 2 is adjusted for age and sex. Model 3 is adjusted for age, sex, body mass index, current smoking, alcohol use in last 12 mo, diabetes mellitus, hypertension, systolic blood pressure, and low-density lipoprotein cholesterol. All characteristics were assessed at visit 1. Only individuals with complete covariates for all models (n=3754) are included. β values reported per standard deviation difference in ln transformed measure. LDL indicates low-density lipoprotein; Max, maximum; Min, minimum; and OR, odds ratio. We also assessed associations of rs2022030 with other coagulation-related biomarkers that were previously measured in MESA and CHS. The F3 lead variant rs2022030 was associated with higher levels of plasmin-antiplasmin complex (β=0.025, SE=0.007, P=0.00043). There were no associations between rs2022030 and either thrombin generation measured ex vivo or selected coagulation/fibrinolysis biomarkers related to TF or extrinsic pathway activation, including circulating levels of soluble TF, factor VIIa, or tissue factor pathway inhibitor (Table I in the online-only Data Supplement).
Chromosome 11 HBB Locus
The second genome-wide significant locus for D-dimer was on chromosome 11. The lead variant, HBB rs334 (p.E6V, EAF 4.2%), which encodes the sickle cell mutation, was associated with higher D-dimer levels (β=0.507, SE=0.065, P=1.41×10 -14 ) and explained 1.97% of the phenotypic variance ( Figure VIA in the online-only Data Supplement). Excluding 2 homozygotes for the minor allele of rs334 did not substantively change this result (β=0.485, P=3.77×10 -13 ). An additional chromosome 11 variant, intergenic indel rs149481026 near OR51V1, was also found to be significant (β=0.490, SE=0.079, P=6.19×10 As rs334 is an African ancestry-specific variant, we confined our replication analysis for this variant to an independent, single-ethnicity sample of N=1933 AA participants from MESA and REGARDS. We found a similar association of HBB rs334 with higher D-dimer levels (β=0.286, SE=0.068, P=2.31×10 -5 ). To investigate the possible mechanism or influence on other coagulation-related parameters, we analyzed the relationship of HBB rs334 genotype with additional coagulation measures available in MESA and REGARDS. We observed no association of HBB rs334 with fibrinogen, plasmin-antiplasmin complex, factor VIII, factor IX, factor XI, or protein C levels ( Table II in 
Gene-Sex Interaction of F3 Variant on D-Dimer Levels
Because D-dimer is higher in women than men, we performed an exploratory whole genome sequencing association analysis stratified by sex in JHS AA. Manhattan and QQ plots are shown in Figure VII in the online-only Data Supplement. No variants were genome-wide significant in men. In women, both the chromosome 1 F3 rs2022030 variant (β=0.373, SE=0.052, P=9.06×10 -13 ) and the chromosome 11 HBB rs334 variant (β=0.523, SE=0.085, P=9.91×10 -10 ) were genomewide significant. The lead variant at the F3 locus in women was rs4609438 (β=0.356, SE=0.048, P=2.72×10 -13 , EAF 12.8%), which is in strong LD (r 2 =0.8) with rs2022030. Though the chromosome 11 HBB rs334 variant did not reach genome-wide significance in men, it had a similar estimated effect in men (β=0.468, SE=0.100, P=3.12×10 -6 , P interaction =0.923) compared with women. In contrast, F3 rs2022030, the lead variant in the sex-combined analyses, had greatly reduced estimated effect size in JHS men (β=0.135, SE=0.072, P=0.062) compared with JHS women. The rs2022030-sex interaction in JHS was significant (P interaction =0.009; Table 3 ).
We next tested for additional evidence of F3 rs2022030-sex interaction in an independent sample of 10 808 multiethnic men In combined analysis of CHS, FHS, and MESA, the effect size of rs2022030 was higher (β=0.073, SE= 0.023) among women than among men (P interaction =0.001). JHS and FHS analyses adjusted for age and the first 10 principal components. CHS and MESA analyses adjusted for age, site, and the first 10 principal components. CHS indicates Cardiovascular Health Study; EA, European American; FHS, Framingham Heart Study; JHS, Jackson Heart Study; MAF, minor allele frequency; and MESA, Multi-Ethnic Study of Atherosclerosis.
and women from MESA, FHS, and CHS (Table 3 ; Figure VIII in the online-only Data Supplement). In the combined analysis for these 3 cohorts, the effect size of rs2022030 was higher (β=0.073, SE=0.023) among women than among men, and this sex difference was also highly significant (P interaction =0.001).
D-Dimer Associated Genetic Variants and Risk of Incident Events in JHS
Finally, we assessed the relationship between D-dimer-associated genetic variants and risk of clinical events in JHS. No significant associations with all-cause mortality, CHD, or stroke were observed for HBB rs334 (Table 4) . For F3 variant rs2022030, nominal associations were observed with increased risk of CHD (HR, 1.43; 95% CI, 1.01-2.03; P=0.045) and stroke (HR, 1.66; 95% CI, 1.11-2.47; P=0.013) in models adjusted for age, sex, and ancestry principal components. The results remained essentially unchanged when adjusted for body mass index, current smoking, alcohol use, diabetes mellitus, hypertension, systolic blood pressure, low-density lipoprotein cholesterol, and C-reactive protein. We also constructed a simple genetic risk score, summing the number of D-dimer raising alleles at rs334 and rs2022030 ( 
Discussion
There were 3 main findings from this study. First, higher D-dimer was confirmed as an independent risk marker for future CVD and total mortality in AAs. Second, both acquired and genetic factors (including those that are shared with ancestral European populations such as F3 rs2022030) contributed to D-dimer variation among AAs. Third, we identified genetic factors that may in part account for sex and ethnic differences in D-dimer. Specifically, the African ancestral sickle cell variant (HBB rs334) was associated with higher D-dimer. Moreover, a sex-specific association of the F3 gene locus was seen in women but not in men, which might explain, in part, the higher D-dimer levels among women compared with men.
Prior studies examining the role of D-dimer in risk prediction of stroke, 6,7 CHD, 6 VTE, 4,5 all CVD, 3 and mortality 9 included both AA and European descent participants. Only one recent study in REGARDS reported the results stratified by race/ethnicity, which suggested a stronger association for CHD than stroke, particularly in AAs. 7 Our results in JHS for the association of D-dimer with these CVD and mortality outcomes in AAs were generally consistent with these prior studies, although our precision was limited by the available sample size. 3, 6, 9 Comparison of results between studies may be complicated by differences in sample sizes and numbers of events, length of follow-up/proximity of clinical events to time of D-dimer measurement, and covariate adjustment, all of which may impact the reported risk estimates.
Among related AA individuals from JHS, we estimated the polygenic heritability of D-dimer as 0.284. Prior studies reported heritability estimates ranging from 0.11 to 0.65. [23] [24] [25] [26] Global or genome-wide estimates of African ancestry have been associated with higher D-dimer levels in some populations, 27 but not others, 28 with a modest positive association observed in JHS. Apart from any differences in genetic architecture of D-dimer levels because of ancestry-specific genetic factors, it is possible that polygenic influences may differ on the basis of age or sex. In the context of the observed F3 genotype-sex interaction we report in JHS, it is interesting to note the relatively higher heritability estimate for D-dimer (65% in female European twin pairs) reported in the one prior study that only included women. 23 To our knowledge, the current report is the first genomewide, sequencing-based association study of D-dimer in a population of African ancestry, including analysis of coding and noncoding variants across the entire allele frequency spectrum. Two prior genetic association analyses of D-dimer in AAs were limited to variants in candidate gene regions. 16, 27 An analysis of variants from 42 coagulation genes in 327 AA participants from CHS found no significant associations. 27 In an analysis of ITMAT-Broad-CARe array data in 2192 AA participants, Weng et al 16 replicated the association of a coding variant in FGA (rs6050) with D-dimer previously observed in European populations.
The genome-wide association of HBB rs334 (sickle cell trait) with D-dimer in JHS is consistent with previous work 5, [29] [30] [31] and the higher risk of VTE with sickle cell trait.
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Although sickle cell disease is a hypercoagulable state, few prior studies have examined hemostatic measures in HBB rs334 heterozygotes. 5, 30, 31, 32 We did not find any association between HBB rs334 and other hemostasis biomarkers, though our analysis may be limited by sample size. The mechanism responsible for higher D-dimer in sickle cell mutation carriers is unknown. Relatively low partial pressure of oxygen and dehydration in certain tissues 33, 34 may lead to erythrocyte sickling and endothelial activation, which may result in tissue damage, exposure of extracellular and intracellular proteins (eg, TF), which ultimately trigger activation of the blood coagulation system. The roles of subclinical rhabdomyolysis, proteinuria, or erythrocyte sickling and resultant erythrocyte phosphatidylserine exposure, protein S levels, and thrombin generation 35 require further investigation to elucidate the mechanisms relating sickle trait to higher D-dimer and VTE risk.
Our results show that the association of the F3 locus with D-dimer initially observed in Europeans 18 generalizes to AAs. F3 encodes TF, a necessary cofactor for factor VIIa in the initiation of the extrinsic blood coagulation pathway. TF is constitutively expressed in various extravascular cells and can be induced in endothelial cells and monocytes/ macrophages by a variety of agonists. According to highresolution chromatin conformation capture assay, our lead variant rs2022030 physically interacts with the F3 promoter region in trophoblast and spleen tissue. 36 In analyses from the MESA cohort, our lead variant was also associated with increased monocyte F3 expression and an increased percentage of TF+lipopolysaccharide-stimulated monocytes. Another LD proxy variant rs143015276 located ≈50 kb upstream of F3 is within promoter marks for lung and cervical tissue and enhancer histone marks for mesenchymal stem cells, skin, muscle, breast, and placental tissue. 37 Taken together, these data suggest a potential regulatory role for one or more of the D-dimer-associated variants on TF expression.
The observed rs2022030-sex interaction at F3 is concordant with higher levels of D-dimer in women 6, 8, 9 (JHS mean 0.49, SD 0.65 in men, 0.62, SD 0.63 in women). Notably, TF expression can be induced by progesterone in human endometrial stromal cells and seems to play a role in reproductive and peripartum hemostasis. 38 A genome-wide significant F3 variant (rs143015276, P=1.34×10 -9 ) in LD with rs2022030 is located within predicted binding motifs for FOXA1, a transcription factor for the estrogen receptor. 37 A previous study did not find any association of the F3 variant and risk of incident VTE 39 ; however, further study of the F3 variant in women and in the contexts of exogenous sex hormones (oral contraceptives, hormone therapy) is warranted.
The connection between D-dimer-associated genetic variants F3 rs2022030, HBB rs334, and CVD events is unclear. While we provide some additional suggestive evidence that D-dimer raising alleles are associated with increased risk of incident CHD and stroke in AA, the interpretation of results is limited by the relatively small number of CVD events in JHS. Moreover, the genetic variant-CVD associations were only partially attenuated by adjustment for D-dimer, suggesting that additional intermediates or pathways may mediate the putative genetic susceptibility. A prior meta-analysis of incident VTE and F3 variant rs12029080 in Europeans found no significant association. 39 Further analyses, including a more formal Mendelian randomization analysis involving considerably larger sample sizes, will be required to clarify the relationship of D-dimer-associated genetic variants to CVD risk, particularly in African ancestry populations.
Several additional limitations of our analysis should be noted. To date, VTE have not been adjudicated within the JHS, so we were unable to assess associations with D-dimer. Much larger sample sizes (currently accruing through whole genome sequencing projects such as TOPMed) may be needed to assess the role of lower frequency variants associated with D-dimer levels. The lack of association between the F3 or HBB variants and other coagulation biomarkers may be because of heterogeneity of participant characteristics or assay methods between studies.
In summary, our results extend the importance of D-dimer as a CVD biomarker and predictor in AAs. Genetic factors, including sickle cell trait and common variants at the F3 locus, contribute to the higher D-dimer levels among AAs and AA women, respectively. Given the role of D-dimer in the clinical evaluation and diagnosis of VTE, and potentially additional vascular conditions, future studies should address the clinical and public health implications of these ethnic and sex-related genetic influences.
